Adcirca 20 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FP8MA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,556
Award facts
- Contract value 100% obligated
- $15,556.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,556.21 to AmerisourceBergen Drug Corp for the supply of Adcirca 20 mg tablets (60-count units) on January 8, 2026, with a completion date of January 9, 2026. This non-set-aside, firm fixed-price delivery order was fulfilled from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., continues to serve as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The IDC encompassing this delivery order covers an extensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This delivery order for Adcirca, a pulmonary hypertension treatment, exemplifies the company's ongoing role in fulfilling essential pharmaceutical needs for the Defense Health Agency and other federal healthcare systems through competitive, open-market procurement mechanisms.
Quick answers
Who was awarded contract SPE2DR26FP8MA?
SPE2DR26FP8MA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FP8MA worth?
The government has obligated $15,556 on SPE2DR26FP8MA.
Is contract SPE2DR26FP8MA an order under another contract?
Yes. SPE2DR26FP8MA is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8MA competed?
The extent of competition for SPE2DR26FP8MA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award